Literature DB >> 23132636

Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.

Hui-Ping Liu1, Zu-Hua Gao, Shu-Xiang Cui, Yan Wang, Bao-Ying Li, Hong-Xiang Lou, Xian-Jun Qu.   

Abstract

Acetyl-11-keto-beta-boswellic acid (AKBA) is a derivative of boswellic acid, which is an active component of the gum resin of Boswellia serrata. AKBA has been used as an adjuvant medication for treatment of inflammatory diseases. In this study, we aimed to evaluate the efficacy of AKBA as a chemopreventive agent against intestinal adenomatous polyposis in the adenomatous polyposis coli multiple intestinal neoplasia (APC(Min/+) ) mouse model. APC(Min/+) mice were administered AKBA by p.o. gavage for 8 consecutive weeks. The mice were sacrificed and the number, size and histopathology of intestinal polyps were examined by light microscopy. AKBA decreased polyp numbers by 48.9% in the small intestine and 60.4% in the colon. An even greater AKBA effect was observed in preventing the malignant progression of these polyps. The number of large (>3 cm) colonic polyposis was reduced by 77.8%. Histopathologic analysis demonstrated a significant reduction in the number of dysplastic cells and in the degree of dysplasia in each polyp after AKBA treatment. There was no evidence of high grade dysplasia or intramucosal carcinoma in any of the polyps examined within the treated group. More interestingly, interdigitated normal appearing intestinal villi were observed in the polyps of the treated group. During the course of the study, AKBA was well tolerated by the mice with no obvious signs of toxicity. Results from immunohistochemical staining, Western blotting and enzyme-linked immunosorbent assay indicated that the chemopreventive effect of AKBA was attributed to a collection of activities including antiproliferation, apoptosis induction, antiangiogenesis and anti-inflammation. AKBA was found to exert its chemopreventive action through the inhibition of the Wnt/β-catenin and NF-κB/cyclooxygenase-2 signaling pathways. Our findings suggest that AKBA could be a promising regimen in chemoprevention against intestinal tumorigenesis.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23132636     DOI: 10.1002/ijc.27929

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

1.  Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties.

Authors:  Yong-Qing Liu; Shi-Kang Wang; Qing-Qing Xu; Hui-Qing Yuan; Yan-Xia Guo; Qian Wang; Feng Kong; Zhao-Min Lin; De-Qing Sun; Rong-Mei Wang; Hong-Xiang Lou
Journal:  Acta Pharmacol Sin       Date:  2018-08-31       Impact factor: 6.150

Review 2.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

3.  The selective 5-LOX inhibitor 11-keto-β-boswellic acid protects against myocardial ischemia reperfusion injury in rats: involvement of redox and inflammatory cascades.

Authors:  Shimaa M Elshazly; Dalia M Abd El Motteleb; Noha N Nassar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-15       Impact factor: 3.000

4.  Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.

Authors:  Yu-Sheng Zhang; Ye Li; Yan Wang; Shi-Yue Sun; Tao Jiang; Cong Li; Shu-Xiang Cui; Xian-Jun Qu
Journal:  J Cancer Res Clin Oncol       Date:  2015-12-24       Impact factor: 4.553

Review 5.  Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

Authors:  Abedul Haque; Daniel Brazeau; Arm R Amin
Journal:  Eur J Cancer       Date:  2021-04-14       Impact factor: 9.162

6.  Analysis of mutations in tumor and normal adjacent tissue via fluorescence detection.

Authors:  Jennifer E Kay; Sheyla Mirabal; William E Briley; Takafumi Kimoto; Theofilos Poutahidis; Timothy Ragan; Peter T So; Dushan N Wadduwage; Susan E Erdman; Bevin P Engelward
Journal:  Environ Mol Mutagen       Date:  2020-12-28       Impact factor: 3.216

7.  Overexpression of SphK2 contributes to ATRA resistance in colon cancer through rapid degradation of cytoplasmic RXRα by K48/K63-linked polyubiquitination.

Authors:  Wen-Na Shi; Shu-Xiang Cui; Zhi-Yu Song; Shu-Qing Wang; Shi-Yue Sun; Xin-Feng Yu; Ye Li; Yu-Hang Zhang; Zu-Hua Gao; Xian-Jun Qu
Journal:  Oncotarget       Date:  2017-06-13

8.  Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model.

Authors:  Bruna Girardi; Maria Pricci; Floriana Giorgio; Mariano Piazzolla; Andrea Iannone; Giuseppe Losurdo; Mariabeatrice Principi; Michele Barone; Enzo Ierardi; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2020-04-14       Impact factor: 5.742

Review 9.  Googling the Guggul (Commiphora and Boswellia) for Prevention of Chronic Diseases.

Authors:  Ajaikumar B Kunnumakkara; Kishore Banik; Devivasha Bordoloi; Choudhary Harsha; Bethsebie L Sailo; Ganesan Padmavathi; Nand K Roy; Subash C Gupta; Bharat B Aggarwal
Journal:  Front Pharmacol       Date:  2018-08-06       Impact factor: 5.810

10.  Chemoprevention of intestinal tumorigenesis by the natural dietary flavonoid myricetin in APCMin/+ mice.

Authors:  Ye Li; Shu-Xiang Cui; Shi-Yue Sun; Wen-Na Shi; Zhi-Yu Song; Shu-Qing Wang; Xin-Feng Yu; Zu-Hua Gao; Xian-Jun Qu
Journal:  Oncotarget       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.